BioCentury | Oct 26, 2015
Clinical News

Aerius regulatory update

...Merck submitted an NDA in Japan for desloratadine to treat allergic rhinitis, hives and itching resulting...
...K.K. subsidiary granted Kyorin Pharmaceutical Co. Ltd. (Tokyo:4569, Tokyo, Japan) co-marketing and co-promotion rights to desloratadine...
...BioCentury, Jan. 12). Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Aerius ( Clarinex ) desloratadine...
BioCentury | Jan 12, 2015
Company News

Merck, Kyorin deal

...Merck’s MSD K.K. subsidiary granted Kyorin co-marketing and co-promotion rights in Japan to desloratadine. The second-generation...
...allergic rhinitis. MSD will receive an upfront payment and is eligible for milestones. Merck markets desloratadine...
BioCentury | Jan 7, 2010
Targets & Mechanisms

HCV cache: the list

...Meda AB Marketed as Astepro for allergic rhinitis; marketed as Optivar for allergic conjunctivitis Clarinex/Aerius desloratadine...
BioCentury | Mar 23, 2009
Company News

Schering-Plough inflammation news

...2001 regarding a delay in approval of an NDA for the company's allergy drug Clarinex desloratadine...
BioCentury | Feb 25, 2008
Clinical News

Aerius regulatory update

...Clarinex in the U.S. Schering-Plough Corp. (NYSE:SGP), Kenilworth, N.J. Product: Aerius , Neoclarityn , Azomyr desloratadine...
BioCentury | May 28, 2007
Clinical News

Aerinaze desloratadine/pseudoephedrine regulatory update

...CHMP issued a positive opinion for the approval of Aerinaze, a combination of 2.5 mg desloratadine...
...treat seasonal allergic rhinitis accompanied by nasal congestion. Schering-Plough Corp. (SGP), Kenilworth, N.J. Product: Aerinaze desloratadine/pseudoephedrine...
BioCentury | May 7, 2007
Clinical News

Clarinex desloratadine regulatory update

...Desloratadine is marketed as Clarinex in the U.S. Schering-Plough Corp. (SGP), Kenilworth, N.J. Product: Clarinex desloratadine...
BioCentury | Dec 4, 2006
Clinical News

Clarinex desloratadine: Post-marketing study data

...other sedating events was >6 times higher with Xyzal levocetirizine vs. desloratadine (p<0.001). SGP markets desloratadine...
...the product in the second half of 2007. Schering-Plough Corp. (SGP), Kenilworth, N.J. Product: Clarinex desloratadine...
BioCentury | Sep 11, 2006
Clinical News

Clarinex desloratadine update

...in patients with persistent or intermittent allergic rhinitis. Schering-Plough Corp. (SGP), Kenilworth, N.J. Product: Clarinex desloratadine...
BioCentury | Feb 6, 2006
Clinical News

Clarinex-D 12 Hour regulatory update

...including nasal congestion, in patients ages 12 and older. The twice-daily combination of 2.5 mg desloratadine...
Items per page:
1 - 10 of 43